Home
Conditions
Solid Tumor

Clinical trial condition

Solid Tumor

Explore clinical trials studying Solid Tumor. Study availability and eligibility vary by location and protocol.

729 public trials 250 recruiting studies

Refine in advanced search Browse all conditions

Solid Tumor trial results

Completed

Study of ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma

NCT03802955

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

Shanghai Dongfang Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017

NCT04144842

Conditions: Neoplasms, Solid Tumor
Locations: Department of Oncology, Skåne University Hospital Lund, Sweden

Fas 1-enheten, Centrum för Kliniska Cancerstudier, Karolinska Universitetssjukhuset Solna, Sweden

Department of Oncology, Uppsala University Hospital Uppsala, Sweden

View Trial Details

Completed

IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors

NCT03758781

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +41 more
Locations: H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors

NCT05126927

Conditions: Solid Tumor
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Completed

First in Human Study of M4344 in Participants With Advanced Solid Tumors

NCT02278250

Conditions: Advanced Solid Tumor, Solid Tumor
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

Washington University in St. Louis St Louis, Missouri, United States

Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View all 16 locations

View Trial Details

Completed

A Study to Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor Subjects

NCT02742935

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +10 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Completed

A Study of Anti-VEGFR2 AK109 in Subjects With Advanced Solid Tumors

NCT04547205

Conditions: Solid Tumor
Locations: The First Affiliated Hospital of Medicine College, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Completed

Clinical Study of KD6001 in Advanced Solid Tumours

NCT05230290

Conditions: Solid Tumor
Locations: Beijing Cancer Hospital Beijing, China

View Trial Details

Completed

A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate SYD1875

NCT04202705

Conditions: Solid Tumor
Locations: Institut Jules Bordet Brussels, Belgium

Institut Bergonié Bordeaux, France

Centre Oscar Lambret Lille, France

View Trial Details

Completed

Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer

NCT01607905

Conditions: Adenocarcinoma, Astrocytoma, Carcinoma, +28 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Karmanos Cancer Institute Detroit, Michigan, United States

Memorial Sloan-Kettering Cancer Center New York, United States

Gabrail Cancer Center Canton, Ohio, United States

View Trial Details

Solid Tumor

Solid Tumor trial results

Related conditions